Home/Filings/4/0000899243-22-003302
4//SEC Filing

Semigran Marc 4

Accession 0000899243-22-003302

CIK 0001799850other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 6:30 PM ET

Size

7.5 KB

Accession

0000899243-22-003302

Insider Transaction Report

Form 4
Period: 2022-01-24
Semigran Marc
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2022-01-24+34,85034,850 total
    Exercise: $6.45Exp: 2032-01-24Common Stock (34,850 underlying)
  • Award

    Common Stock

    2022-01-24+17,42552,651 total
Footnotes (2)
  • [F1]These restricted stock units will vest in four equal annual installments beginning on January 24, 2023, subject to continued service with the Company.
  • [F2]The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in equal monthly installments on the24th of each month for the remaining 36months, subject to the continuous service of the Reporting Person on such vesting date.

Issuer

Renovacor, Inc.

CIK 0001799850

Entity typeother

Related Parties

1
  • filerCIK 0001691494

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:30 PM ET
Size
7.5 KB